Name/Surname:
Aris Dimitrios AngouridiS
Date of Birth:
Mobile Phone:
Work Phone:
+357 22559641
Email:
A.Angouridis@euc.ac.cy
Address:
European University of Cyprus
6, Diogenous Str, 2404 Engomi, Nicosia
P.O. Box:22006,1516 Nicosia-Cyprus
| 2018-Today | Lecturer of Internal Medicine/Pathophysiology, European University Cyprus ,Nicosia, Cyprus |
| 2015 | Specialty Training post, General University Hospital of Ioannina, Ioannina, Greece |
| 2015 | Honorary Clinical Research Fellow, Royal Free Hospital, London, UK |
| Clinical Research Fellow, Outpatient Lipid Clinic of the University Hospital of Ioannina, Ioannina Greece |
| 2018 | Lecturer, School of Medicine, European University Cyprus |
| 2017 | PhD, Medical School, University of Ioannina, Greece, “Efficacy of high-dose rosuvastatin versus low-dose rosuvastatin plus fenofibrate versus low-dose rosuvastatin plus omega-3 fatty acids in the treatment of mixed hyperlipidemia” |
| 2007 | MD, Medical School, National and Kapodistrian University of Athens, Greece |
| 2018-To date | Lecturer, European University ,Cyprus |
| Date | Title | Awarded by: |
| 2014-2015 | Honorary Clinical Research Fellow in the Department of Clinical Biochemistry, Royal Free Hospital, London, after receiving a scholarship | Hellenic Atherosclerosis Society |
| Journals & Congresses Publications | # |
| Journal Publications | 40 |
| Congresses presentations | # |
| Citations | 453 |
| H – Index (Scopus/ISI) | 13 |
| Books & Book Chapters | # |
| Research protocols | # |
- Yiallouris A, Tsioutis C, Agapidaki E, Zafeiri M, Agouridis AP, Ntourakis D, Johnson EO. (2019). Adrenal Aging and Its Implications on Stress Responsiveness in Humans. Endocrinol., 07 February 2019 | https://doi.org/10.3389/fendo.2019.00054
- Agouridis AP, Kostapanos MS, Elisaf MS (2015). Statins and their increased risk of inducing diabetes. Expert Opin Drug Saf. 2015;14(12):1835-44. doi: 10.1517/14740338.2015.1096343. Epub 2015 Oct 5
- Kostapanos MS, Agouridis AP, Elisaf MS. (2015). Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. DOI:1007/s00125-015-3633-5
- Agouridis AP, Nair DR, Mikhailidis DP. (2015). Strategies to overcome statin intolerance. Expert Opin Drug Metab Toxicol. 2015 Jun;11(6):851-5. doi: 10.1517/17425255.2015.1027685. Epub 2015 Mar 18. DOI:1517/17425255.2015.1027685
- Agouridis AP, Liberopoulos EN, Kostapanos MS, Elisaf MS (2012). New-onset extremely low levels of high-density lipoprotein cholesterol. J Clin Lipidol. 2012 Nov-Dec;6(6):593-5. doi: 10.1016/j.jacl.2012.06.009. Epub 2012 Jul 4.
- Agouridis AP, Kostapanos MS, Tsimihodimos V, Kostara C, Mikhailidis DP, Bairaktari ET, Tselepis AD, Elisaf MS. (2012). Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome. Int J Clin Pract. 2012 Sep;66(9):843-53. doi: 10.1111/j.1742-1241.2012.02972.x.
- Agouridis AP, Tsimihodimos V, Filippatos TD, Dimitriou AA, Tellis CC, Elisaf MS, Mikhailidis DP, Tselepis AD. (2011). The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. Expert Opin Pharmacother. 2011 Dec;12(17):2605-11. doi: 10.1517/14656566.2011.591383. Epub 2011 Jun 29.
- Agouridis AP, Tsimihodimos V, Filippatos TD, Tselepis AD, Elisaf MS (2011). High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia. 2011 Jun;46(6):521-8. doi: 10.1007/s11745-011-3538-0. Epub 2011 Feb 15